Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $725.65 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Actelion Pharmaceuticals US, Inc. | $132.10 | 1 | $0 (2017) |
| PFIZER INC. | $125.77 | 9 | $0 (2020) |
| Theravance Biopharma, Inc. | $124.82 | 1 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $102.63 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $68.28 | 4 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $40.21 | 3 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $38.68 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $21.20 | 1 | $0 (2019) |
| Shire North American Group Inc | $19.74 | 1 | $0 (2018) |
| AbbVie Inc. | $15.12 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $29.36 | 2 | AbbVie Inc. ($15.12) |
| 2020 | $43.21 | 3 | PFIZER INC. ($43.21) |
| 2019 | $264.03 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($102.63) |
| 2018 | $198.34 | 6 | Theravance Biopharma, Inc. ($124.82) |
| 2017 | $190.71 | 5 | Actelion Pharmaceuticals US, Inc. ($132.10) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2021 | Vapotherm Inc | VAPOTHERM (Device) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: RESPIRATORY | ||||||
| 06/02/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/12/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/04/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/28/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/19/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.63 | General |
| Category: Cardiovascular | ||||||
| 12/04/2019 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/12/2019 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/10/2019 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/18/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/13/2019 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/27/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/21/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $102.63 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/25/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.05 | General |
| Category: Cardiovascular | ||||||
| 03/12/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/09/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 05/08/2018 | Abbott Laboratories | FreeStyle Libre blood glucose Flash Monitoring System (Device) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Diabetes Care | ||||||
| 04/13/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 04/10/2018 | Shire North American Group Inc | GATTEX (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: INTERNAL MEDICINE | ||||||
| 04/04/2018 | Theravance Biopharma, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $124.82 | General |
| Category: Infectious Disease | ||||||
| 02/01/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/10/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug), SIVEXTRO | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/30/2017 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 554 | 1,025 | $216,883 | $79,549 |
| 2022 | 6 | 497 | 903 | $212,141 | $69,235 |
| 2021 | 4 | 515 | 893 | $138,017 | $70,200 |
| 2020 | 5 | 616 | 969 | $134,650 | $73,145 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 161 | 372 | $85,932 | $33,694 | 39.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 164 | 418 | $67,298 | $25,209 | 37.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 103 | 104 | $24,648 | $9,006 | 36.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 50 | 51 | $22,899 | $6,336 | 27.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 40 | 40 | $6,440 | $2,221 | 34.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $5,508 | $1,805 | 32.8% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 18 | 22 | $4,158 | $1,279 | 30.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 196 | 545 | $125,895 | $41,802 | 33.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 143 | 144 | $34,128 | $11,076 | 32.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 59 | 59 | $26,491 | $7,987 | 30.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 61 | 109 | $17,549 | $5,826 | 33.2% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 16 | 24 | $4,536 | $1,410 | 31.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 22 | 22 | $3,542 | $1,136 | 32.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 258 | 597 | $91,656 | $46,981 | 51.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 134 | 137 | $23,469 | $11,037 | 47.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 88 | 124 | $12,583 | $6,820 | 54.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 35 | 35 | $10,309 | $5,362 | 52.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 261 | 481 | $72,150 | $38,930 | 54.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 224 | 357 | $35,700 | $20,218 | 56.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 62 | 62 | $10,230 | $5,121 | 50.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 29 | 29 | $8,410 | $4,567 | 54.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 40 | 40 | $8,160 | $4,310 | 52.8% |
About Dr. Ragan Vaughan, D.O
Dr. Ragan Vaughan, D.O is a Hospitalist healthcare provider based in Muskogee, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2011. The National Provider Identifier (NPI) number assigned to this provider is 1801174065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ragan Vaughan, D.O has received a total of $725.65 in payments from pharmaceutical and medical device companies, with $29.36 received in 2021. These payments were reported across 27 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($725.65).
As a Medicare-enrolled provider, Vaughan has provided services to 2,182 Medicare beneficiaries, totaling 3,790 services with total Medicare billing of $292,130. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Hospitalist
- Location Muskogee, OK
- Active Since 07/21/2011
- Last Updated 02/18/2022
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1801174065
Products in Payments
- ELIQUIS (Drug) $138.96
- VIBATIV (Drug) $124.82
- RELISTOR (Drug) $102.63
- XARELTO (Drug) $68.28
- ZERBAXA (Drug) $26.59
- CHANTIX (Drug) $25.49
- ENTRESTO (Drug) $21.20
- GATTEX (Drug) $19.74
- DALVANCE (Drug) $15.12
- VAPOTHERM (Device) $14.24
- DIFICID (Drug) $13.62
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $12.05
- BRILINTA (Drug) $10.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Muskogee
Soumya Kidiyoor, M.d, M.D
Hospitalist — Payments: $2,856
Dr. Deepak Karibassappa, Md, MD
Hospitalist — Payments: $2,707
Dr. Dharshan Lakshminarayan, M.d, M.D
Hospitalist — Payments: $1,188
Kendall Allmaras
Hospitalist — Payments: $495.74
Dr. Jameson Pelton, Do, DO
Hospitalist — Payments: $306.96
Dr. Michael Hilborn, Do, DO
Hospitalist — Payments: $301.62